[Hemostatic profile of women using low-dose oral contraceptive Mercilon. (Preliminary report)]

Akusherstvo I Ginekologiia
|July 31, 2002
PubMed

The authors have investigated the hemostatic profile at 20 women using low-dosed oral contraceptive Mercilon (Organon) in continuation of six months. Statistically significant changes are found for factor X of hemocoagulation, plasminogen, protein C, protein S and antithrombin III. It is concluded that Mercilon causes activation of the coagulation system, which is balanced by the activation of the fibrinolytic system.